Last reviewed · How we verify

NCT07053865

Electromyographic Assessment of Sleep Bruxism in Patients With Stage III and IV Periodontitis

Completed Last updated 4 September 2025
What this trial tests

trial testing Surface Electromyography (dia-BRUXO) in Bruxism in 40 participants. Completed in 31 July 2025.

Timeline
27 June 2025
Primary endpoint
31 July 2025
31 July 2025

Quick facts

Lead sponsorUniversity of Siena
StatusCompleted
Study typeOBSERVATIONAL
Enrollment40
Start date27 June 2025
Primary completion31 July 2025
Estimated completion31 July 2025
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

University of Siena

Who can join

Adults 28 to 50, any sex, with Bruxism or Periodontitis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to investigate the association between periodontitis Stage III and IV and the intensity and duration of sleep bruxism episodes. Surface electromyography (EMG) of the masseter muscle will be used to instrumentally assess sleep bruxism in patients with and without periodontal disease

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Bruxism

Currently open trials in the same condition.

Other University of Siena trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07053865.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing